Cargando…
Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study
BACKGROUND: The role of the gut microbiota in Crohn’s disease (CD) is established and fecal microbiota transplantation (FMT) is an attractive therapeutic strategy. No randomized controlled clinical trial results are available. We performed a randomized, single-blind, sham-controlled pilot trial of F...
Autores principales: | Sokol, Harry, Landman, Cecilia, Seksik, Philippe, Berard, Laurence, Montil, Mélissa, Nion-Larmurier, Isabelle, Bourrier, Anne, Le Gall, Guillaume, Lalande, Valérie, De Rougemont, Alexis, Kirchgesner, Julien, Daguenel, Anne, Cachanado, Marine, Rousseau, Alexandra, Drouet, Élodie, Rosenzwajg, Michelle, Hagege, Hervé, Dray, Xavier, Klatzman, David, Marteau, Philippe, Beaugerie, Laurent, Simon, Tabassome |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998149/ https://www.ncbi.nlm.nih.gov/pubmed/32014035 http://dx.doi.org/10.1186/s40168-020-0792-5 |
Ejemplares similares
-
Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease
por: Le Gall, Guillaume, et al.
Publicado: (2018) -
Factors affecting outcomes in Crohn's disease over 15 years
por: Cosnes, Jacques, et al.
Publicado: (2012) -
Fungal microbiota dysbiosis in IBD
por: Sokol, Harry, et al.
Publicado: (2017) -
Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases
por: Michaudel, Chloé, et al.
Publicado: (2023) -
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer
por: Lavelle, Aonghus, et al.
Publicado: (2022)